UPDATE : Wednesday, February 20, 2019
Novo Nordisk has high expectations for GLP-1 receptor agonists
Novo Nordisk is confident that 2019 will be another good business year ridi...
by Kim Yun-mi  |  2019-02-08 17:11
Bioneer’s HIV diagnostic kit registered on Global Fund’s purchase list
Bioneer said its human immunodeficiency virus type 1 (HIV-1) diagnostic kit...
by Park Gi-taek  |  2019-02-08 16:46
‘Total homocysteine increases risk of cerebral infarction’
Researchers at Seoul National University Boramea Hospital have discovered t...
by Lee Han-soo  |  2019-02-08 16:13
Pangen wins Malaysia’s nod for epoetin alfa biosimilar
Pangen said Thursday that Malaysia’s National Pharmaceutical Regulatory Age...
by Lee Han-soo  |  2019-02-08 16:13
Sanofi seeks to add cholesterol-lowering drug’s new indication in Korea
Sanofi is preparing to seek an additional indication of Praluent (alirocuma...
by Kim Yun-mi  |  2019-02-08 16:12
Multinationals prepare next-generation pneumococcal vaccines
Multinational pharmaceutical firms are gearing up to replace conventional p...
by Kim Yun-mi  |  2019-02-08 12:02
Kainos Medicine starts developing treatment for multiple system atrophy
Kainos Medicine said Friday that it would develop a treatment for multiple ...
by Lee Han-soo  |  2019-02-08 11:47
‘Novartis’ Cosentyx, a cost-effective alternative to Humira’
Novartis said Thursday that Cosentyx (Ingredient: secukinumab), its interle...
by Lee Han-soo  |  2019-02-07 17:14
Seoul accepts Bayer’s request to reduce study subjects of cancer drug
The government has accepted Bayer’s request to reduce the number of review ...
by Lee Hye-seon  |  2019-02-07 16:06
FDA starts inspecting SK Biopharm’s epilepsy treatment
SK Biopharmaceutical said Thursday that the U.S. Food and Drug Administrati...
by Lee Han-soo  |  2019-02-07 16:01
LSK Global PS to conduct clinical trials of Mediforum’s dementia treatment
Mediforum has signed a contract research agency contract with LSK Global PS...
by Lee Han-soo  |  2019-02-07 14:40
MSD’s immunotherapy Keytruda outpaces BMS’ Opdivo in sales
MSD’s cancer immunotherapy Keytruda (ingredient: pembrolizumab) beat Bristo...
by Kim Yun-mi  |  2019-02-07 14:40
Korean firms ink $232 million surgical device export deals in Dubai
Korean medical device makers showcased an integrated showroom of surgical d...
by Park Gi-taek  |  2019-02-07 11:55
FDA OKs Daewoong’s BTX
Daewoong Pharmaceutical said that it received approval from the U.S. Food a...
by Lee Han-soo  |  2019-02-07 11:09
EM physician from Korea enjoys work-life balance in America
She had a solid reason to live as a doctor in the United States: She wanted...
by Song Soo-youn  |  2019-02-06 06:00
[Special] Why did these med students become YouTubers?
People today are living in an era of YouTube. It exerts enormous influence ...
by Cho In-sung  |  2019-02-05 07:27
[Special] Nearly one-third of children under 5 suffer from chronic malnutrition
It is lunchtime and children rushed seemingly from nowhere. The cafeteria t...
by Yoon Won-sub  |  2019-02-04 06:00
Pfizer feeling bittersweet over Korea’s biosimilars
Pfizer has lately seen both positive and negative impacts of Korean biosimi...
by Lee Han-soo  |  2019-02-01 17:04
Dementia drug Exelon’s insurance coverage expanded for Parkinson’s disease
Novartis Korea’s dementia treatment Exelon (rivastigmine) obtained expanded...
by Kim Yun-mi  |  2019-02-01 17:02
‘Alunbrig works better for ALK-positive non-small cell lung cancer’
Second-line treatment options are increasing for patients with anaplastic l...
by Kim Yun-mi  |  2019-02-01 15:38
Back to Top